The role of miR-122 in the dysregulation of glucose-6-phosphate dehydrogenase (G6PD) expression in hepatocellular cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-018-27358-5.pdf
Reference50 articles.
1. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385, 117–171, https://doi.org/10.1016/s0140-6736(14)61682-2 (2015).
2. Llovet, J. M. et al. Hepatocellular carcinoma. Nature Reviews. Disease Primers 2, 16018, https://doi.org/10.1038/nrdp.2016.18 (2016).
3. Llovet, J. M. et al. Sorafenib in advanced hepatocellular carcinoma. The New England Journal of Medicine 359, 378–390, https://doi.org/10.1056/NEJMoa0708857 (2008).
4. El-Khoueiry, A. B. et al. Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial. Lancet 389, 2492–2502, https://doi.org/10.1016/s0140-6736(17)31046-2 (2017).
5. Bruix, J. et al. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 389, 56–66, https://doi.org/10.1016/s0140-6736(16)32453-9 (2017).
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. G6PD is a prognostic biomarker correlated with immune infiltrates in lung adenocarcinoma and pulmonary arterial hypertension;Aging;2024-01-08
2. Glucose metabolism in B cell malignancies: a focus on glycolysis branching pathways;Molecular Oncology;2024-01-03
3. Glucose-6-Phosphate Dehydrogenase Enzyme;Reference Module in Biomedical Sciences;2024
4. Clinical and therapeutical significances of the cluster and signature based on oxidative stress for osteosarcoma;Aging;2023-12-29
5. The role and mechanism of action of microRNA-122 in cancer: Focusing on the liver;International Immunopharmacology;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3